(Total Views: 637)
Posted On: 07/28/2020 1:36:34 PM
Post# of 154952
That advertising campaign vs Tocilizumab and Sarilumab would be quite straightforward:
"We know how rough Rheumatoid Arthritis can be... would you like liver dysfunction or pancreatic cancer in addition? How about Adverse Cardiac Events? Nasty secondary infections? No? Well then you'll want Leronlimab"
"We know how rough Rheumatoid Arthritis can be... would you like liver dysfunction or pancreatic cancer in addition? How about Adverse Cardiac Events? Nasty secondary infections? No? Well then you'll want Leronlimab"
(5)
(0)
